| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3282829 | Clinical Gastroenterology and Hepatology | 2013 | 17 Pages |
Abstract
We detected mutant TP53 in secretin-stimulated pancreatic juice samples collected from duodena of patients with high-grade dysplasia or invasive pancreatic cancer. Tests for mutant TP53 might be developed to improve the diagnosis of and screening for pancreatic cancer and high-grade dysplasia. Clinical Trial numbers: NCT00438906 and NCT00714701.
Keywords
HRMEUSCAPSIPMNMRCPEndoscopic retrograde cholangiopancreatographyMRIBiomarkerDiagnosticEarly detectionmagnetic resonance cholangiopancreatographyMagnetic resonance imagingTumorendoscopic ultrasonographyintraductal papillary mucinous neoplasmpancreatic intraepithelial neoplasiapolymerase chain reactionPCRPanINERCP یا endoscopic retrograde cholangiopancreatography
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Mitsuro Kanda, Yoshihiko Sadakari, Michael Borges, Mark Topazian, James Farrell, Sapna Syngal, Jeffrey Lee, Ihab Kamel, Anne Marie Lennon, Spencer Knight, Sho Fujiwara, Ralph H. Hruban, Marcia Irene Canto, Michael Goggins,